UA125138U - METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinoma - Google Patents
METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinomaInfo
- Publication number
- UA125138U UA125138U UAU201712922U UAU201712922U UA125138U UA 125138 U UA125138 U UA 125138U UA U201712922 U UAU201712922 U UA U201712922U UA U201712922 U UAU201712922 U UA U201712922U UA 125138 U UA125138 U UA 125138U
- Authority
- UA
- Ukraine
- Prior art keywords
- prolactinoma
- patients
- determination
- therapy
- therapeutic tactics
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Спосіб визначення терапевтичної тактики у хворих на пролактиноми щодо призначення початкових доз каберголіну. Визначають такі критерії як вік хворого, розмір аденоми гіпофіза, рівень пролактину в сироватці крові, наявність попереднього хірургічного лікування, променевої терапії та/або терапії агоністами дофаміну, виразність клінічної симптоматики та в залежності від їх значення призначають режим поступового нарощування дози препарату або режим високих доз супресивної терапії.Method for determining therapeutic tactics in patients with prolactinoma for administration of initial doses of cabergoline. Determine such criteria as the patient's age, size of pituitary adenoma, serum prolactin level, the presence of previous surgical treatment, radiation therapy and / or dopamine agonist therapy, the severity of clinical symptoms and, depending on their importance, prescribe a gradual increase in dosage regimen suppressive therapy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201712922U UA125138U (en) | 2017-12-26 | 2017-12-26 | METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201712922U UA125138U (en) | 2017-12-26 | 2017-12-26 | METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinoma |
Publications (1)
Publication Number | Publication Date |
---|---|
UA125138U true UA125138U (en) | 2018-04-25 |
Family
ID=62027421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201712922U UA125138U (en) | 2017-12-26 | 2017-12-26 | METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinoma |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA125138U (en) |
-
2017
- 2017-12-26 UA UAU201712922U patent/UA125138U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ603780A (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer | |
MX2017009047A (en) | Dosage regimen for madcam antagonists. | |
NZ601111A (en) | Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies | |
EA201892347A1 (en) | METHOD AND DEVICE FOR PROVIDING PHARMACOKINETIC SCHEME OF DOSING OF DRUGS | |
EA201700123A1 (en) | METHOD FOR PREDICTING A VARIANT OF A MEDICAL PREPARATION FOR THE TREATMENT OF DEPRESSION | |
MX2020006660A (en) | Biomarkers of methotrexate-induced immune tolerance. | |
UA125138U (en) | METHOD OF DETERMINATION OF THERAPEUTIC TACTICS IN PATIENTS WITH prolactinoma | |
MX2017003015A (en) | A method of treating solid cancers and/or metastases thereof, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereof. | |
WO2022109588A3 (en) | Cancer drug sensitivity determining markers | |
Chou et al. | FES for abnormal movement of upper limb during walking in post-stroke subjects | |
MX2021015717A (en) | Methods for predicting drug responsiveness in cancer patients. | |
Godhwani | Methylprednisolone sodium succinate | |
Montoro De Francisco | Local pustulosis: case report | |
Sampedro-Nunez et al. | Association of angiopoietin/TIE2 plasma level and VEGF system with progression in gastroenteropancreatic neuroendocrine tumors | |
UA112621U (en) | METHOD OF CORRECTION OF ENDOTHELY DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES | |
Budny | Achilles rupture: case report | |
Anderson | Haloperidol/olanzapine/valproate | |
Hassan | Reactive arthritis following intravesicular administration: case report | |
Kong et al. | Analysis of malaria situation and discussion of control strategy in Shandong province, 2013 | |
Knowlton | Triggering of right thumb and left little finger: case report | |
Nakai | Acute generalised exanthematous pustulosis: case report | |
Pekoz | Kaposi sarcoma: case report | |
Giannoudis et al. | Reflex Sympathetic Dystrophy Syndrome | |
Venisse et al. | Rifampicin dramatically decreases clindamycin plasma concentrations in patients treated for bone/joint infections. | |
Allouchery | Pyrazinamide/rifampicin |